MICHELLE GENRE: Open Payments
NPI 1568594414 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,429 in 63 payments from 15 companies in 2025. Trend: 2023 $1,526 · 2024 $857 · 2025 $1,429
Food & beverage: $1,329Education: $100
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 6 | $229 |
| UROGEN PHARMA, INC. | 5 | $193 |
| ABBVIE INC. | 13 | $192 |
| Astellas Pharma US Inc | 3 | $143 |
| Antares Pharma, Inc. | 10 | $142 |
| Sumitomo Pharma America, Inc. | 5 | $123 |
| Janssen Biotech, Inc. | 5 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| Endo USA, Inc. | 3 | $55 |
| Boston Scientific Corporation | 2 | $46 |
Products named: PROVENGE, BOTOX, XYOSTED, JELMYTO, GEMTESA, ERLEADA, XTANDI, Nubeqa.
Industry payments across LA — which companies pay providers there.
